BlackRock Health Sciences Trust’s (BME) (the 'Trust') investment objective is to provide total return through a combination of current income,
current gains and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at
least 80% of its assets in equity securities of companies engaged in the health sciences and related industries and equity derivatives with exposure to
the health sciences industry. The Trust utilizes an option writing (selling) strategy to enhance dividend yield.
No assurance can be given that the Trust’s investment objective will be achieved.
ACCESS TO RESILIENCY AND GROWTH IN HEALTHCARE
Seeks to invest in healthcare companies with strong pipelines and potential long-term growth opportunities
DIVERSIFIED EXPOSURE ACROSS THE HEALTHCARE SECTOR
Access to the full spectrum of sector opportunities, investing across pharmaceuticals, biotechnology, medical devices and healthcare providers
SEEKS TO REDUCE PORTFOLIO VOLATILITY
Sells (writes) call options on underlying equity portfolio, potentially reducing the fund’s volatility